142 related articles for article (PubMed ID: 27074937)
1. Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging.
Kang M; Song B; Lee I; Lee SE; Byun SS; Hong SK
World J Urol; 2016 Nov; 34(11):1541-1546. PubMed ID: 27074937
[TBL] [Abstract][Full Text] [Related]
2. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
BJU Int; 2017 Jan; 119(1):57-66. PubMed ID: 26823024
[TBL] [Abstract][Full Text] [Related]
5. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
[TBL] [Abstract][Full Text] [Related]
6. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
[TBL] [Abstract][Full Text] [Related]
7. Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities.
Leyh-Bannurah SR; Abou-Haidar H; Dell'Oglio P; Schiffmann J; Tian Z; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
BJU Int; 2017 May; 119(5):692-699. PubMed ID: 27367469
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy.
Renard Penna R; Cancel-Tassin G; Comperat E; Mozer P; Léon P; Varinot J; Roupret M; Bitker MO; Lucidarme O; Cussenot O
World J Urol; 2016 Oct; 34(10):1389-95. PubMed ID: 26902878
[TBL] [Abstract][Full Text] [Related]
10. Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer.
Porcaro AB; Siracusano S; Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Mattevi D; Inverardi D; Cerruto MA; Brunelli M; Artibani W
Tumori; 2018; 104(2):111-115. PubMed ID: 27791231
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low-risk prostate cancer.
Porcaro AB; Inverardi D; Corsi P; Sebben M; Cacciamani G; Tafuri A; Processali T; Pirozzi M; Mattevi D; De Marchi D; Amigoni N; Rizzetto R; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Minerva Urol Nefrol; 2020 Feb; 72(1):66-71. PubMed ID: 30298710
[TBL] [Abstract][Full Text] [Related]
12. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer.
Dinh KT; Mahal BA; Ziehr DR; Muralidhar V; Chen YW; Viswanathan VB; Nezolosky MD; Beard CJ; Choueiri TK; Martin NE; Orio PF; Sweeney CJ; Trinh QD; Nguyen PL
J Urol; 2015 Aug; 194(2):343-9. PubMed ID: 25681290
[TBL] [Abstract][Full Text] [Related]
14. Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
Jpn J Clin Oncol; 2013 May; 43(5):553-8. PubMed ID: 23580758
[TBL] [Abstract][Full Text] [Related]
15. Elevated fatty acid synthase expression in prostate needle biopsy cores predicts upgraded Gleason score in radical prostatectomy specimens.
Hamada S; Horiguchi A; Kuroda K; Ito K; Asano T; Miyai K; Iwaya K
Prostate; 2014 Jan; 74(1):90-6. PubMed ID: 24108439
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.
Kamrava M; Kishan AU; Margolis DJ; Huang J; Dorey F; Lieu P; Kupelian PA; Marks LS
Pract Radiat Oncol; 2015; 5(6):411-6. PubMed ID: 26059510
[TBL] [Abstract][Full Text] [Related]
17. MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary Report.
Tafuri A; Panunzio A; Greco F; Maglietta A; De Carlo F; Di Cosmo F; Luperto E; Rizzo M; Cavaliere A; De Mitri R; Zacheo F; Baviello M; Cimino A; Pisino M; Giordano L; Accettura C; Porcaro AB; Antonelli A; Cerruto MA; Ciurlia E; Leo S; Quarta LG; Pagliarulo V;
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498069
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
